Q Pula Trading Management LP Amgen Inc Transaction History

Q Pula Trading Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $306,152 - $340,693	1,327 New	1,327 $323,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $229,137 - $253,485	-1,045 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $83,728 - $95,819	-421 Reduced 28.72%	1,045 $235,000
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $311,187 - $364,594	1,466 New	1,466 $312,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

Stay updated on Q Pula Trading Management LP with notifications on news.